Who
Adam S. Grossman
President and CEO
Company insider
Files Form 4 as: President and CEO, ADMA Biologics.
In numbers
- Trades disclosed
- 211
- Buys
- 37
- Sells
- 19
- Bought
- $4.3M
- Sold
- $21.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Feb 2012
- Last trade
- 16 Mar 2026
- Last filed
- 17 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Mar 2026filed 17 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code M | $81K15,000 at $5.40 | filing |
| 16 Mar 2026filed 17 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Sold | $227K15,000 at $15.16 | filing |
| 16 Mar 2026filed 17 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Sold | $91K6,000 at $15.16 | filing |
| 16 Mar 2026filed 17 Mar 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 16 Mar 2026filed 17 Mar 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 16 Mar 2026filed 17 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code M | $81K15,000 at $5.40 | filing |
| 16 Mar 2026filed 17 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Sold | $227K15,000 at $15.16 | filing |
| 16 Mar 2026filed 17 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Sold | $91K6,000 at $15.16 | filing |
| 7 Mar 2026filed 10 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $454K29,513 at $15.39 | filing |
| 7 Mar 2026filed 10 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $454K29,513 at $15.39 | filing |
| 6 Mar 2026filed 10 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $869K56,438 at $15.39 | filing |
| 6 Mar 2026filed 10 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $869K56,438 at $15.39 | filing |
| 26 Feb 2026filed 2 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $833K54,858 at $15.18 | filing |
| 26 Feb 2026filed 2 Mar 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $833K54,858 at $15.18 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $405K24,793 at $16.32 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $405K24,793 at $16.32 | filing |
| 17 Feb 2026filed 17 Feb 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code M | $81K15,000 at $5.40 | filing |
| 17 Feb 2026filed 17 Feb 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Sold | $241K15,000 at $16.08 | filing |
| 17 Feb 2026filed 17 Feb 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Sold | $96K6,000 at $16.08 | filing |
| 17 Feb 2026filed 17 Feb 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
News
Contrasting Rhythm Pharmaceuticals (NASDAQ:RYTM) & ADMA Biologics (NASDAQ:ADMA)ADMA · dailypolitical.com · 22 Oct 2026Arcturus Therapeutics (NASDAQ:ARCT) & ADMA Biologics (NASDAQ:ADMA) Head-To-Head SurveyADMA · dailypolitical.com · 18 Oct 2026Analyzing Anika Therapeutics (NASDAQ:ANIK) & ADMA Biologics (NASDAQ:ADMA)ADMA · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Adam S. Grossman; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.